The Chemours Company (NYSE:CC – Get Free Report)’s share price dropped 7.5% on Monday . The stock traded as low as $11.93 and last traded at $11.9840. Approximately 1,031,669 shares changed hands during trading, a decline of 69% from the average daily volume of 3,347,992 shares. The stock had previously closed at $12.95.
Analysts Set New Price Targets
CC has been the subject of a number of recent research reports. Zacks Research downgraded shares of Chemours from a “hold” rating to a “strong sell” rating in a research report on Friday, October 17th. Mizuho cut their price target on Chemours from $19.00 to $18.00 and set an “outperform” rating for the company in a report on Thursday, October 16th. JPMorgan Chase & Co. decreased their price objective on Chemours from $15.00 to $13.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 3rd. UBS Group cut their price objective on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Tuesday, November 11th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a report on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $17.00.
Check Out Our Latest Analysis on Chemours
Chemours Stock Up 0.4%
Chemours (NYSE:CC – Get Free Report) last announced its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.04). The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The business’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.40 earnings per share. As a group, equities analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current fiscal year.
Chemours Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a $0.0875 dividend. The ex-dividend date was Friday, November 14th. This represents a $0.35 dividend on an annualized basis and a yield of 3.0%. Chemours’s dividend payout ratio (DPR) is presently -15.77%.
Institutional Trading of Chemours
Hedge funds have recently bought and sold shares of the business. Hudson Bay Capital Management LP purchased a new stake in shares of Chemours in the third quarter valued at approximately $1,925,000. Penn Capital Management Company LLC purchased a new position in shares of Chemours during the 3rd quarter worth approximately $10,325,000. CIBC Bancorp USA Inc. acquired a new stake in Chemours in the 3rd quarter valued at approximately $254,000. Caitong International Asset Management Co. Ltd acquired a new position in Chemours during the third quarter worth $43,000. Finally, Advisory Services Network LLC purchased a new position in shares of Chemours during the third quarter worth $54,000. Institutional investors and hedge funds own 76.26% of the company’s stock.
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Read More
- Five stocks we like better than Chemours
- How to Buy Cheap Stocks Step by Step
- Is Tesla Overvalued? 2 Reasons It Might Be a Bargain
- 3 Warren Buffett Stocks to Buy Now
- How These 2 Stocks Won 2025’s AI RaceāAnd What’s In Store for 2026
- What is Forex and How Does it Work?
- Intel Snaps Up AI Tech for Pennies on the Dollar
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.
